{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:16:02Z","timestamp":1792016162576,"version":"4.4.0"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1A4A4079494"],"award-info":[{"award-number":["2020R1A4A4079494"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1A2C2004052"],"award-info":[{"award-number":["2019R1A2C2004052"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s12272-020-01281-8","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T11:06:28Z","timestamp":1604919988000},"page":"1144-1161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":407,"title":["Ubiquitin\u2013proteasome system (UPS) as a target for anticancer treatment"],"prefix":"10.1007","volume":"43","author":[{"given":"Jinyoung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2420-6666","authenticated-orcid":false,"given":"Eun Joo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"issue":"1","key":"1281_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.molcel.2016.05.009","volume":"63","author":"SA Abdul Rehman","year":"2016","unstructured":"Abdul Rehman SA, Kristariyanto YA, Choi SY, Nkosi PJ, Weidlich S, Labib K, Hofmann K, Kulathu Y (2016) MINDY-1 is a member of an evolutionarily conserved and structurally distinct new family of deubiquitinating enzymes. Mol Cell 63(1):146\u2013155. https:\/\/doi.org\/10.1016\/j.molcel.2016.05.009","journal-title":"Mol Cell"},{"issue":"5","key":"1281_CR2","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.2353\/ajpath.2010.091075","volume":"177","author":"N Amodio","year":"2010","unstructured":"Amodio N, Scrima M, Palaia L, Salman AN, Quintiero A, Franco R, Botti G, Pirozzi P, Rocco G, De Rosa N, Viglietto G (2010) Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas. Am J Pathol 177(5):2622\u20132634. https:\/\/doi.org\/10.2353\/ajpath.2010.091075","journal-title":"Am J Pathol"},{"key":"1281_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061579","author":"AM Antao","year":"2020","unstructured":"Antao AM, Tyagi A, Kim KS, Ramakrishna S (2020) Advances in deubiquitinating enzyme inhibition and applications in cancer therapeutics. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12061579","journal-title":"Cancers (Basel)"},{"issue":"9","key":"1281_CR4","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1158\/1078-0432.CCR-10-1950","volume":"17","author":"S Arastu-Kapur","year":"2011","unstructured":"Arastu-Kapur S, Anderl JL, Kraus M, Parlati F, Shenk KD, Lee SJ, Muchamuel T, Bennett MK, Driessen C, Ball AJ, Kirk CJ (2011) Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events. Clin Cancer Res 17(9):2734\u20132743. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1950","journal-title":"Clin Cancer Res"},{"issue":"13","key":"1281_CR5","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1093\/emboj\/18.13.3575","volume":"18","author":"CS Arendt","year":"1999","unstructured":"Arendt CS, Hochstrasser M (1999) Eukaryotic 20S proteasome catalytic subunit propeptides prevent active site inactivation by N-terminal acetylation and promote particle assembly. EMBO J 18(13):3575\u20133585. https:\/\/doi.org\/10.1093\/emboj\/18.13.3575","journal-title":"EMBO J"},{"issue":"5","key":"1281_CR6","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/med.21675","volume":"40","author":"MD Asmamaw","year":"2020","unstructured":"Asmamaw MD, Liu Y, Zheng YC, Shi XJ, Liu HM (2020) Skp2 in the ubiquitin-proteasome system: a comprehensive review. Med Res Rev 40(5):1920\u20131949. https:\/\/doi.org\/10.1002\/med.21675","journal-title":"Med Res Rev"},{"key":"1281_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41420-020-0237-8","volume":"6","author":"A Aubry","year":"2020","unstructured":"Aubry A, Yu T, Bremner R (2020) Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy. Cell Death Discov 6:2. https:\/\/doi.org\/10.1038\/s41420-020-0237-8","journal-title":"Cell Death Discov"},{"issue":"7","key":"1281_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.tcb.2010.03.007","volume":"20","author":"L Bedford","year":"2010","unstructured":"Bedford L, Paine S, Sheppard PW, Mayer RJ, Roelofs J (2010) Assembly, structure, and function of the 26S proteasome. Trends Cell Biol 20(7):391\u2013401. https:\/\/doi.org\/10.1016\/j.tcb.2010.03.007","journal-title":"Trends Cell Biol"},{"key":"1281_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41392-018-0012-y","volume":"3","author":"S Bhattacharya","year":"2018","unstructured":"Bhattacharya S, Chakraborty D, Basu M, Ghosh MK (2018) Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases. Signal Transduct Target Ther 3:17. https:\/\/doi.org\/10.1038\/s41392-018-0012-y","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"1281_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/76006","volume":"25","author":"GR Bignell","year":"2000","unstructured":"Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, Green H, Brown C, Biggs PJ, Lakhani SR, Jones C, Hansen J, Blair E, Hofmann B, Siebert R, Turner G, Evans DG, Schrander-Stumpel C, Beemer FA, van Den Ouweland A, Halley D, Delpech B, Cleveland MG, Leigh I, Leisti J, Rasmussen S (2000) Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 25(2):160\u2013165. https:\/\/doi.org\/10.1038\/76006","journal-title":"Nat Genet"},{"issue":"32","key":"1281_CR11","doi-asserted-by":"publisher","first-page":"E4639","DOI":"10.1073\/pnas.1608644113","volume":"113","author":"O Braten","year":"2016","unstructured":"Braten O, Livneh I, Ziv T, Admon A, Kehat I, Caspi LH, Gonen H, Bercovich B, Godzik A, Jahandideh S, Jaroszewski L, Sommer T, Kwon YT, Guharoy M, Tompa P, Ciechanover A (2016) Numerous proteins with unique characteristics are degraded by the 26S proteasome following monoubiquitination. Proc Natl Acad Sci USA 113(32):E4639\u2013E4647. https:\/\/doi.org\/10.1073\/pnas.1608644113","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"1281_CR12","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1158\/1541-7786.MCR-12-0699","volume":"11","author":"RA Burkhart","year":"2013","unstructured":"Burkhart RA, Peng Y, Norris ZA, Tholey RM, Talbott VA, Liang Q, Ai Y, Miller K, Lal S, Cozzitorto JA, Witkiewicz AK, Yeo CJ, Gehrmann M, Napper A, Winter JM, Sawicki JA, Zhuang Z, Brody JR (2013) Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survival. Mol Cancer Res 11(8):901\u2013911. https:\/\/doi.org\/10.1158\/1541-7786.MCR-12-0699","journal-title":"Mol Cancer Res"},{"issue":"2","key":"1281_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.yexcr.2009.08.018","volume":"316","author":"A Byrne","year":"2010","unstructured":"Byrne A, McLaren RP, Mason P, Chai L, Dufault MR, Huang Y, Liang B, Gans JD, Zhang M, Carter K, Gladysheva TB, Teicher BA, Biemann HP, Booker M, Goldberg MA, Klinger KW, Lillie J, Madden SL, Jiang Y (2010) Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest and senescence. Exp Cell Res 316(2):258\u2013271. https:\/\/doi.org\/10.1016\/j.yexcr.2009.08.018","journal-title":"Exp Cell Res"},{"issue":"3","key":"1281_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2013.06.048","volume":"154","author":"CH Chan","year":"2013","unstructured":"Chan CH, Morrow JK, Li CF, Gao Y, Jin G, Moten A, Stagg LJ, Ladbury JE, Cai Z, Xu D, Logothetis CJ, Hung MC, Zhang S, Lin HK (2013) Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell 154(3):556\u2013568. https:\/\/doi.org\/10.1016\/j.cell.2013.06.048","journal-title":"Cell"},{"issue":"16","key":"1281_CR16","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1158\/1078-0432.CCR-11-0476","volume":"17","author":"D Chauhan","year":"2011","unstructured":"Chauhan D, Tian Z, Zhou B, Kuhn D, Orlowski R, Raje N, Richardson P, Anderson KC (2011) In vitro and in vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN9708 against multiple myeloma cells. Clin Cancer Res 17(16):5311\u20135321. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0476","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1281_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ccr.2012.08.007","volume":"22","author":"D Chauhan","year":"2012","unstructured":"Chauhan D, Tian Z, Nicholson B, Kumar KG, Zhou B, Carrasco R, McDermott JL, Leach CA, Fulcinniti M, Kodrasov MP, Weinstock J, Kingsbury WD, Hideshima T, Shah PK, Minvielle S, Altun M, Kessler BM, Orlowski R, Richardson P, Munshi N, Anderson KC (2012) A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 22(3):345\u2013358. https:\/\/doi.org\/10.1016\/j.ccr.2012.08.007","journal-title":"Cancer Cell"},{"issue":"4","key":"1281_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/095632020901900402","volume":"19","author":"X Chen","year":"2009","unstructured":"Chen X, Chou CY, Chang GG (2009) Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme. Antivir Chem Chemother 19(4):151\u2013156. https:\/\/doi.org\/10.1177\/095632020901900402","journal-title":"Antivir Chem Chemother"},{"issue":"11","key":"1281_CR17","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.chembiol.2011.08.014","volume":"18","author":"J Chen","year":"2011","unstructured":"Chen J, Dexheimer TS, Ai Y, Liang Q, Villamil MA, Inglese J, Maloney DJ, Jadhav A, Simeonov A, Zhuang Z (2011a) Selective and cell-active inhibitors of the USP1\/UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells. Chem Biol 18(11):1390\u20131400. https:\/\/doi.org\/10.1016\/j.chembiol.2011.08.014","journal-title":"Chem Biol"},{"issue":"2","key":"1281_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/cbf.1734","volume":"29","author":"Z Chen","year":"2011","unstructured":"Chen Z, Niu X, Li Z, Yu Y, Ye X, Lu S, Chen Z (2011b) Effect of ubiquitin carboxy-terminal hydrolase 37 on apoptotic in A549 cells. Cell Biochem Funct 29(2):142\u2013148. https:\/\/doi.org\/10.1002\/cbf.1734","journal-title":"Cell Biochem Funct"},{"issue":"9","key":"1281_CR18","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.leukres.2015.06.004","volume":"39","author":"S Chen","year":"2015","unstructured":"Chen S, Xing H, Li S, Yu J, Li H, Liu S, Tian Z, Tang K, Rao Q, Wang M, Wang J (2015) Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells. Leuk Res 39(9):976\u2013983. https:\/\/doi.org\/10.1016\/j.leukres.2015.06.004","journal-title":"Leuk Res"},{"issue":"7","key":"1281_CR21","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1182\/blood-2010-09-306019","volume":"117","author":"Y Chu","year":"2011","unstructured":"Chu Y, Vahl JC, Kumar D, Heger K, Bertossi A, Wojtowicz E, Soberon V, Schenten D, Mack B, Reutelshofer M, Beyaert R, Amann K, van Loo G, Schmidt-Supprian M (2011) B cells lacking the tumor suppressor TNFAIP3\/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice. Blood 117(7):2227\u20132236. https:\/\/doi.org\/10.1182\/blood-2010-09-306019","journal-title":"Blood"},{"issue":"1","key":"1281_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrm1552","volume":"6","author":"A Ciechanover","year":"2005","unstructured":"Ciechanover A (2005) Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol 6(1):79\u201387. https:\/\/doi.org\/10.1038\/nrm1552","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"1281_CR23","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1016\/j.oraloncology.2009.02.004","volume":"45","author":"SD da Silva","year":"2009","unstructured":"da Silva SD, Cunha IW, Nishimoto IN, Soares FA, Carraro DM, Kowalski LP, Graner E (2009) Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas. Oral Oncol 45(10):e134\u2013e139. https:\/\/doi.org\/10.1016\/j.oraloncology.2009.02.004","journal-title":"Oral Oncol"},{"issue":"3","key":"1281_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41416-018-0355-8","volume":"120","author":"VA de Weger","year":"2019","unstructured":"de Weger VA, de Jonge M, Langenberg MHG, Schellens JHM, Lolkema M, Varga A, Demers B, Thomas K, Hsu K, Tuffal G, Goodstal S, Mace S, Deutsch E (2019) A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours. Br J Cancer 120(3):286\u2013293. https:\/\/doi.org\/10.1038\/s41416-018-0355-8","journal-title":"Br J Cancer"},{"issue":"14","key":"1281_CR25","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1021\/jm400487c","volume":"56","author":"Q Ding","year":"2013","unstructured":"Ding Q, Zhang Z, Liu JJ, Jiang N, Zhang J, Ross TM, Chu XJ, Bartkovitz D, Podlaski F, Janson C, Tovar C, Filipovic ZM, Higgins B, Glenn K, Packman K, Vassilev LT, Graves B (2013) Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development. J Med Chem 56(14):5979\u20135983. https:\/\/doi.org\/10.1021\/jm400487c","journal-title":"J Med Chem"},{"issue":"5","key":"1281_CR26","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/S0021-9258(19)39896-5","volume":"265","author":"VM Dixit","year":"1990","unstructured":"Dixit VM, Green S, Sarma V, Holzman LB, Wolf FW, O\u2019Rourke K, Ward PA, Prochownik EV, Marks RM (1990) Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem 265(5):2973\u20132978","journal-title":"J Biol Chem"},{"issue":"14","key":"1281_CR27","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1016\/j.yexcr.2007.04.027","volume":"313","author":"T Dohda","year":"2007","unstructured":"Dohda T, Maljukova A, Liu L, Heyman M, Grander D, Brodin D, Sangfelt O, Lendahl U (2007) Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines. Exp Cell Res 313(14):3141\u20133152. https:\/\/doi.org\/10.1016\/j.yexcr.2007.04.027","journal-title":"Exp Cell Res"},{"issue":"146","key":"1281_CR28","doi-asserted-by":"publisher","first-page":"ra80","DOI":"10.1126\/scisignal.2001462","volume":"3","author":"Z Du","year":"2010","unstructured":"Du Z, Song J, Wang Y, Zhao Y, Guda K, Yang S, Kao HY, Xu Y, Willis J, Markowitz SD, Sedwick D, Ewing RM, Wang Z (2010) DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci Signal 3(146):ra80. https:\/\/doi.org\/10.1126\/scisignal.2001462","journal-title":"Sci Signal"},{"issue":"1","key":"1281_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/cdd.2009.82","volume":"17","author":"AG Eldridge","year":"2010","unstructured":"Eldridge AG, O\u2019Brien T (2010) Therapeutic strategies within the ubiquitin proteasome system. Cell Death Differ 17(1):4\u201313. https:\/\/doi.org\/10.1038\/cdd.2009.82","journal-title":"Cell Death Differ"},{"issue":"1","key":"1281_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bbamcr.2013.06.027","volume":"1843","author":"ZM Eletr","year":"2014","unstructured":"Eletr ZM, Wilkinson KD (2014) Regulation of proteolysis by human deubiquitinating enzymes. Biochim Biophys Acta 1843(1):114\u2013128. https:\/\/doi.org\/10.1016\/j.bbamcr.2013.06.027","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"1281_CR31","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1349-7006.2006.00239.x","volume":"97","author":"Y Fujii","year":"2006","unstructured":"Fujii Y, Yada M, Nishiyama M, Kamura T, Takahashi H, Tsunematsu R, Susaki E, Nakagawa T, Matsumoto A, Nakayama KI (2006) Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation. Cancer Sci 97(8):729\u2013736. https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00239.x","journal-title":"Cancer Sci"},{"issue":"4","key":"1281_CR32","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/ijc.24399","volume":"125","author":"T Fujita","year":"2009","unstructured":"Fujita T, Liu W, Doihara H, Wan Y (2009) An in vivo study of Cdh1\/APC in breast cancer formation. Int J Cancer 125(4):826\u2013836. https:\/\/doi.org\/10.1002\/ijc.24399","journal-title":"Int J Cancer"},{"issue":"4","key":"1281_CR33","first-page":"467","volume":"20","author":"M Fukuda","year":"2006","unstructured":"Fukuda M, Fukuda F, Horiuchi Y, Oku Y, Suzuki S, Kusama K, Sakashita H (2006) Expression of CYLD, NF-kappaB and NF-kappaB-related factors in salivary gland tumors. In Vivo 20(4):467\u2013472","journal-title":"In Vivo"},{"issue":"6","key":"1281_CR34","first-page":"1421","volume":"19","author":"M Fukuda","year":"2008","unstructured":"Fukuda M, Hiroi M, Suzuki S, Ohmori Y, Sakashita H (2008) Loss of CYLD might be associated with development of salivary gland tumors. Oncol Rep 19(6):1421\u20131427","journal-title":"Oncol Rep"},{"issue":"57","key":"1281_CR35","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.18632\/oncotarget.27219","volume":"10","author":"S Fukui","year":"2019","unstructured":"Fukui S, Nagasaka K, Miyagawa Y, Kikuchi-Koike R, Kawata Y, Kanda R, Ichinose T, Sugihara T, Hiraike H, Wada-Hiraike O, Sasajima Y, Ayabe T (2019) The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-beta\/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer. Oncotarget 10(57):5932\u20135948. https:\/\/doi.org\/10.18632\/oncotarget.27219","journal-title":"Oncotarget"},{"issue":"7","key":"1281_CR36","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ncb1742","volume":"10","author":"I Garcia-Higuera","year":"2008","unstructured":"Garcia-Higuera I, Manchado E, Dubus P, Canamero M, Mendez J, Moreno S, Malumbres M (2008) Genomic stability and tumour suppression by the APC\/C cofactor Cdh1. Nat Cell Biol 10(7):802\u2013811. https:\/\/doi.org\/10.1038\/ncb1742","journal-title":"Nat Cell Biol"},{"issue":"5","key":"1281_CR37","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/cdd.2012.169","volume":"20","author":"S Giovinazzi","year":"2013","unstructured":"Giovinazzi S, Morozov VM, Summers MK, Reinhold WC, Ishov AM (2013) USP7 and Daxx regulate mitosis progression and taxane sensitivity by affecting stability of Aurora-A kinase. Cell Death Differ 20(5):721\u2013731. https:\/\/doi.org\/10.1038\/cdd.2012.169","journal-title":"Cell Death Differ"},{"issue":"5","key":"1281_CR38","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/s0092-8674(00)81603-7","volume":"94","author":"MH Glickman","year":"1998","unstructured":"Glickman MH, Rubin DM, Coux O, Wefes I, Pfeifer G, Cjeka Z, Baumeister W, Fried VA, Finley D (1998) A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94(5):615\u2013623. https:\/\/doi.org\/10.1016\/s0092-8674(00)81603-7","journal-title":"Cell"},{"issue":"3","key":"1281_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1535-6108(04)00055-8","volume":"5","author":"E Graner","year":"2004","unstructured":"Graner E, Tang D, Rossi S, Baron A, Migita T, Weinstein LJ, Lechpammer M, Huesken D, Zimmermann J, Signoretti S, Loda M (2004) The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell 5(3):253\u2013261. https:\/\/doi.org\/10.1016\/S1535-6108(04)00055-8","journal-title":"Cancer Cell"},{"issue":"23","key":"1281_CR40","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1038\/onc.2015.367","volume":"35","author":"C Greil","year":"2016","unstructured":"Greil C, Krohs J, Schnerch D, Follo M, Felthaus J, Engelhardt M, Wasch R (2016) The role of APC\/C(Cdh1) in replication stress and origin of genomic instability. Oncogene 35(23):3062\u20133070. https:\/\/doi.org\/10.1038\/onc.2015.367","journal-title":"Oncogene"},{"issue":"11","key":"1281_CR41","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1128\/MCB.00305-12","volume":"32","author":"JE Grim","year":"2012","unstructured":"Grim JE, Knoblaugh SE, Guthrie KA, Hagar A, Swanger J, Hespelt J, Delrow JJ, Small T, Grady WM, Nakayama KI, Clurman BE (2012) Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer. Mol Cell Biol 32(11):2160\u20132167. https:\/\/doi.org\/10.1128\/MCB.00305-12","journal-title":"Mol Cell Biol"},{"issue":"6624","key":"1281_CR42","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/386463a0","volume":"386","author":"M Groll","year":"1997","unstructured":"Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, Huber R (1997) Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386(6624):463\u2013471. https:\/\/doi.org\/10.1038\/386463a0","journal-title":"Nature"},{"issue":"7","key":"1281_CR43","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1517\/14728220903045018","volume":"13","author":"Q Guo","year":"2009","unstructured":"Guo Q, Dong H, Liu X, Wang C, Liu N, Zhang J, Li B, Cao W, Ding T, Yang Z, Zhang X (2009) A20 is overexpressed in glioma cells and may serve as a potential therapeutic target. Expert Opin Ther Targets 13(7):733\u2013741. https:\/\/doi.org\/10.1517\/14728220903045018","journal-title":"Expert Opin Ther Targets"},{"key":"1281_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fcell.2018.00011","volume":"6","author":"I Gupta","year":"2018","unstructured":"Gupta I, Singh K, Varshney NK, Khan S (2018) Delineating crosstalk mechanisms of the ubiquitin proteasome system that regulate apoptosis. Front Cell Dev Biol 6:11. https:\/\/doi.org\/10.3389\/fcell.2018.00011","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"1281_CR45","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1074\/jbc.M307050200","volume":"279","author":"A Guterman","year":"2004","unstructured":"Guterman A, Glickman MH (2004) Complementary roles for Rpn11 and Ubp6 in deubiquitination and proteolysis by the proteasome. J Biol Chem 279(3):1729\u20131738. https:\/\/doi.org\/10.1074\/jbc.M307050200","journal-title":"J Biol Chem"},{"issue":"4","key":"1281_CR46","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/embor.2012.12","volume":"13","author":"MV Hadjihannas","year":"2012","unstructured":"Hadjihannas MV, Bernkopf DB, Bruckner M, Behrens J (2012) Cell cycle control of Wnt\/beta-catenin signalling by conductin\/axin2 through CDC20. EMBO Rep 13(4):347\u2013354. https:\/\/doi.org\/10.1038\/embor.2012.12","journal-title":"EMBO Rep"},{"issue":"6","key":"1281_CR48","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/mc.22793","volume":"57","author":"Y Han","year":"2018","unstructured":"Han Y, Song C, Wang J, Tang H, Peng Z, Lu S (2018) HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway. Mol Carcinog 57(6):722\u2013734. https:\/\/doi.org\/10.1002\/mc.22793","journal-title":"Mol Carcinog"},{"issue":"1","key":"1281_CR47","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1038\/s41467-019-11618-7","volume":"10","author":"T Han","year":"2019","unstructured":"Han T, Jiang S, Zheng H, Yin Q, Xie M, Little MR, Yin X, Chen M, Song SJ, Beg AA, Pandolfi PP, Wan L (2019) Interplay between c-Src and the APC\/C co-activator Cdh1 regulates mammary tumorigenesis. Nat Commun 10(1):3716. https:\/\/doi.org\/10.1038\/s41467-019-11618-7","journal-title":"Nat Commun"},{"issue":"1","key":"1281_CR49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbrc.2006.06.095","volume":"347","author":"S Hayashi","year":"2006","unstructured":"Hayashi S, Ozaki T, Yoshida K, Hosoda M, Todo S, Akiyama S, Nakagawara A (2006) p73 and MDM2 confer the resistance of epidermoid carcinoma to cisplatin by blocking p53. Biochem Biophys Res Commun 347(1):60\u201366. https:\/\/doi.org\/10.1016\/j.bbrc.2006.06.095","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1281_CR50","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132(3):344\u2013362. https:\/\/doi.org\/10.1016\/j.cell.2008.01.020","journal-title":"Cell"},{"issue":"7","key":"1281_CR51","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1074\/jbc.RA119.010724","volume":"295","author":"Y He","year":"2020","unstructured":"He Y, Wang S, Tong J, Jiang S, Yang Y, Zhang Z, Xu Y, Zeng Y, Cao B, Moran MF, Mao X (2020) The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. J Biol Chem 295(7):2084\u20132096. https:\/\/doi.org\/10.1074\/jbc.RA119.010724","journal-title":"J Biol Chem"},{"issue":"1","key":"1281_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/carcin\/bgl081","volume":"28","author":"C Hellerbrand","year":"2007","unstructured":"Hellerbrand C, Bumes E, Bataille F, Dietmaier W, Massoumi R, Bosserhoff AK (2007) Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis 28(1):21\u201327. https:\/\/doi.org\/10.1093\/carcin\/bgl081","journal-title":"Carcinogenesis"},{"issue":"1","key":"1281_CR53","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41467-018-03148-5","volume":"9","author":"T Hermanns","year":"2018","unstructured":"Hermanns T, Pichlo C, Woiwode I, Klopffleisch K, Witting KF, Ovaa H, Baumann U, Hofmann K (2018) A family of unconventional deubiquitinases with modular chain specificity determinants. Nat Commun 9(1):799. https:\/\/doi.org\/10.1038\/s41467-018-03148-5","journal-title":"Nat Commun"},{"issue":"4","key":"1281_CR54","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/cncr.22073","volume":"107","author":"DD Hershko","year":"2006","unstructured":"Hershko DD, Shapira M (2006) Prognostic role of p27Kip1 deregulation in colorectal cancer. Cancer 107(4):668\u2013675. https:\/\/doi.org\/10.1002\/cncr.22073","journal-title":"Cancer"},{"key":"1281_CR55","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel B, Schmid JA (2013) The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer 12:86. https:\/\/doi.org\/10.1186\/1476-4598-12-86","journal-title":"Mol Cancer"},{"issue":"3","key":"1281_CR56","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/eji.201041313","volume":"41","author":"N Hovelmeyer","year":"2011","unstructured":"Hovelmeyer N, Reissig S, Xuan NT, Adams-Quack P, Lukas D, Nikolaev A, Schluter D, Waisman A (2011) A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur J Immunol 41(3):595\u2013601. https:\/\/doi.org\/10.1002\/eji.201041313","journal-title":"Eur J Immunol"},{"issue":"9","key":"1281_CR57","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1158\/1535-7163.MCT-13-0123","volume":"12","author":"J Hu","year":"2013","unstructured":"Hu J, Van Valckenborgh E, Xu D, Menu E, De Raeve H, De Bruyne E, Xu S, Van Camp B, Handisides D, Hart CP, Vanderkerken K (2013) Synergistic induction of apoptosis in multiple myeloma cells by bortezomib and hypoxia-activated prodrug TH-302, in vivo and in vitro. Mol Cancer Ther 12(9):1763\u20131773. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0123","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"1281_CR58","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1073\/pnas.0406789102","volume":"102","author":"H Huang","year":"2005","unstructured":"Huang H, Regan KM, Wang F, Wang D, Smith DI, van Deursen JM, Tindall DJ (2005) Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci USA 102(5):1649\u20131654. https:\/\/doi.org\/10.1073\/pnas.0406789102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1281_CR59","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccr.2009.08.020","volume":"16","author":"HC Huang","year":"2009","unstructured":"Huang HC, Shi J, Orth JD, Mitchison TJ (2009) Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 16(4):347\u2013358. https:\/\/doi.org\/10.1016\/j.ccr.2009.08.020","journal-title":"Cancer Cell"},{"issue":"3","key":"1281_CR61","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.3892\/ol.2017.6532","volume":"14","author":"ZJ Huang","year":"2017","unstructured":"Huang ZJ, Zhu JJ, Yang XY, Biskup E (2017) NEDD4 promotes cell growth and migration via PTEN\/PI3K\/AKT signaling in hepatocellular carcinoma. Oncol Lett 14(3):2649\u20132656. https:\/\/doi.org\/10.3892\/ol.2017.6532","journal-title":"Oncol Lett"},{"issue":"7","key":"1281_CR60","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1002\/ijc.32615","volume":"146","author":"X Huang","year":"2020","unstructured":"Huang X, Gu H, Zhang E, Chen Q, Cao W, Yan H, Chen J, Yang L, Lv N, He J, Yi Q, Cai Z (2020) The NEDD4-1 E3 ubiquitin ligase: a potential molecular target for bortezomib sensitivity in multiple myeloma. Int J Cancer 146(7):1963\u20131978. https:\/\/doi.org\/10.1002\/ijc.32615","journal-title":"Int J Cancer"},{"issue":"11","key":"1281_CR62","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1073\/pnas.92.7.2563","volume":"92","author":"JM Huibregtse","year":"1995","unstructured":"Huibregtse JM, Scheffner M, Beaudenon S, Howley PM (1995) A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc Natl Acad Sci USA 92(11):5249. https:\/\/doi.org\/10.1073\/pnas.92.7.2563","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1281_CR63","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.molcel.2009.04.031","volume":"34","author":"JE Hutti","year":"2009","unstructured":"Hutti JE, Shen RR, Abbott DW, Zhou AY, Sprott KM, Asara JM, Hahn WC, Cantley LC (2009) Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. Mol Cell 34(4):461\u2013472. https:\/\/doi.org\/10.1016\/j.molcel.2009.04.031","journal-title":"Mol Cell"},{"issue":"2","key":"1281_CR64","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1349-7006.2010.01801.x","volume":"102","author":"M Ibusuki","year":"2011","unstructured":"Ibusuki M, Yamamoto Y, Shinriki S, Ando Y, Iwase H (2011) Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients. Cancer Sci 102(2):439\u2013445. https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01801.x","journal-title":"Cancer Sci"},{"issue":"8","key":"1281_CR65","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1002\/ijc.24879","volume":"126","author":"M Iwatsuki","year":"2010","unstructured":"Iwatsuki M, Mimori K, Ishii H, Yokobori T, Takatsuno Y, Sato T, Toh H, Onoyama I, Nakayama KI, Baba H, Mori M (2010) Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance. Int J Cancer 126(8):1828\u20131837. https:\/\/doi.org\/10.1002\/ijc.24879","journal-title":"Int J Cancer"},{"issue":"11","key":"1281_CR66","doi-asserted-by":"publisher","first-page":"e2474","DOI":"10.1038\/cddis.2016.371","volume":"7","author":"AM Jacko","year":"2016","unstructured":"Jacko AM, Nan L, Li S, Tan J, Zhao J, Kass DJ, Zhao Y (2016) De-ubiquitinating enzyme, USP11, promotes transforming growth factor beta-1 signaling through stabilization of transforming growth factor beta receptor II. Cell Death Dis 7(11):e2474. https:\/\/doi.org\/10.1038\/cddis.2016.371","journal-title":"Cell Death Dis"},{"key":"1281_CR67","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1038\/oncsis.2013.28","volume":"2","author":"H Jung","year":"2013","unstructured":"Jung H, Kim BG, Han WH, Lee JH, Cho JY, Park WS, Maurice MM, Han JK, Lee MJ, Finley D, Jho EH (2013) Deubiquitination of dishevelled by Usp14 is required for Wnt signaling. Oncogenesis 2:e64. https:\/\/doi.org\/10.1038\/oncsis.2013.28","journal-title":"Oncogenesis"},{"key":"1281_CR68","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/bs.pmch.2015.10.002","volume":"55","author":"M Kemp","year":"2016","unstructured":"Kemp M (2016) Recent advances in the discovery of deubiquitinating enzyme inhibitors. Prog Med Chem 55:149\u2013192. https:\/\/doi.org\/10.1016\/bs.pmch.2015.10.002","journal-title":"Prog Med Chem"},{"issue":"11","key":"1281_CR69","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/sj.onc.1210799","volume":"27","author":"T Kidokoro","year":"2008","unstructured":"Kidokoro T, Tanikawa C, Furukawa Y, Katagiri T, Nakamura Y, Matsuda K (2008) CDC20, a potential cancer therapeutic target, is negatively regulated by p53. Oncogene 27(11):1562\u20131571. https:\/\/doi.org\/10.1038\/sj.onc.1210799","journal-title":"Oncogene"},{"issue":"6","key":"1281_CR70","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.4161\/cc.11.6.19550","volume":"11","author":"J Kim","year":"2012","unstructured":"Kim J, Kim WJ, Liu Z, Loda M, Freeman MR (2012) The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer. Cell Cycle 11(6):1123\u20131130. https:\/\/doi.org\/10.4161\/cc.11.6.19550","journal-title":"Cell Cycle"},{"issue":"5540","key":"1281_CR71","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1126\/science.1065203","volume":"294","author":"DM Koepp","year":"2001","unstructured":"Koepp DM, Schaefer LK, Ye X, Keyomarsi K, Chu C, Harper JW, Elledge SJ (2001) Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294(5540):173\u2013177. https:\/\/doi.org\/10.1126\/science.1065203","journal-title":"Science"},{"issue":"8","key":"1281_CR72","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrm2731","volume":"10","author":"D Komander","year":"2009","unstructured":"Komander D, Clague MJ, Urbe S (2009) Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 10(8):550\u2013563. https:\/\/doi.org\/10.1038\/nrm2731","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"1281_CR73","first-page":"2001","volume":"10","author":"S Kondo","year":"1995","unstructured":"Kondo S, Barnett GH, Hara H, Morimura T, Takeuchi J (1995) MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis. Oncogene 10(10):2001\u20132006","journal-title":"Oncogene"},{"issue":"9","key":"1281_CR74","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1182\/blood-2007-01-065888","volume":"110","author":"DJ Kuhn","year":"2007","unstructured":"Kuhn DJ, Chen Q, Voorhees PM, Strader JS, Shenk KD, Sun CM, Demo SD, Bennett MK, van Leeuwen FW, Chanan-Khan AA, Orlowski RZ (2007) Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma. Blood 110(9):3281\u20133290. https:\/\/doi.org\/10.1182\/blood-2007-01-065888","journal-title":"Blood"},{"key":"1281_CR76","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.R110.003871","author":"MJ Lee","year":"2011","unstructured":"Lee MJ, Lee BH, Hanna J, King RW, Finley D (2011) Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes. Mol Cell Proteom. https:\/\/doi.org\/10.1074\/mcp.R110.003871","journal-title":"Mol Cell Proteom"},{"issue":"10","key":"1281_CR75","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/ncb3609","volume":"19","author":"JH Lee","year":"2017","unstructured":"Lee JH, Jung SM, Yang KM, Bae E, Ahn SG, Park JS, Seo D, Kim M, Ha J, Lee J, Kim JH, Kim JH, Ooshima A, Park J, Shin D, Lee YS, Lee S, van Loo G, Jeong J, Kim SJ, Park SH (2017) A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1. Nat Cell Biol 19(10):1260\u20131273. https:\/\/doi.org\/10.1038\/ncb3609","journal-title":"Nat Cell Biol"},{"issue":"5","key":"1281_CR78","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nchembio.2326","volume":"13","author":"J Li","year":"2017","unstructured":"Li J, Yakushi T, Parlati F, Mackinnon AL, Perez C, Ma Y, Carter KP, Colayco S, Magnuson G, Brown B, Nguyen K, Vasile S, Suyama E, Smith LH, Sergienko E, Pinkerton AB, Chung TDY, Palmer AE, Pass I, Hess S, Cohen SM, Deshaies RJ (2017) Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11. Nat Chem Biol 13(5):486\u2013493. https:\/\/doi.org\/10.1038\/nchembio.2326","journal-title":"Nat Chem Biol"},{"issue":"1","key":"1281_CR77","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13046-019-1069-3","volume":"38","author":"C Li","year":"2019","unstructured":"Li C, Du L, Ren Y, Liu X, Jiao Q, Cui D, Wen M, Wang C, Wei G, Wang Y, Ji A, Wang Q (2019) SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination. J Exp Clin Cancer Res 38(1):76. https:\/\/doi.org\/10.1186\/s13046-019-1069-3","journal-title":"J Exp Clin Cancer Res"},{"issue":"13","key":"1281_CR79","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1084\/jem.20092641","volume":"207","author":"J Liang","year":"2010","unstructured":"Liang J, Saad Y, Lei T, Wang J, Qi D, Yang Q, Kolattukudy PE, Fu M (2010) MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-kappaB signaling. J Exp Med 207(13):2959\u20132973. https:\/\/doi.org\/10.1084\/jem.20092641","journal-title":"J Exp Med"},{"issue":"2","key":"1281_CR80","doi-asserted-by":"publisher","first-page":"e2585","DOI":"10.1038\/cddis.2016.477","volume":"8","author":"Y Liao","year":"2017","unstructured":"Liao Y, Liu N, Hua X, Cai J, Xia X, Wang X, Huang H, Liu J (2017) Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor. Cell Death Dis 8(2):e2585. https:\/\/doi.org\/10.1038\/cddis.2016.477","journal-title":"Cell Death Dis"},{"issue":"14","key":"1281_CR81","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/s41388-017-0069-z","volume":"37","author":"Y Liao","year":"2018","unstructured":"Liao Y, Xia X, Liu N, Cai J, Guo Z, Li Y, Jiang L, Dou QP, Tang D, Huang H, Liu J (2018) Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination. Oncogene 37(14):1896\u20131910. https:\/\/doi.org\/10.1038\/s41388-017-0069-z","journal-title":"Oncogene"},{"issue":"5","key":"1281_CR83","doi-asserted-by":"publisher","first-page":"e5544","DOI":"10.1371\/journal.pone.0005544","volume":"4","author":"H Liu","year":"2009","unstructured":"Liu H, Buus R, Clague MJ, Urbe S (2009) Regulation of ErbB2 receptor status by the proteasomal DUB POH1. PLoS ONE 4(5):e5544. https:\/\/doi.org\/10.1371\/journal.pone.0005544","journal-title":"PLoS ONE"},{"issue":"3","key":"1281_CR84","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/cdd.2012.147","volume":"20","author":"PY Liu","year":"2013","unstructured":"Liu PY, Xu N, Malyukova A, Scarlett CJ, Sun YT, Zhang XD, Ling D, Su SP, Nelson C, Chang DK, Koach J, Tee AE, Haber M, Norris MD, Toon C, Rooman I, Xue C, Cheung BB, Kumar S, Marshall GM, Biankin AV, Liu T (2013) The histone deacetylase SIRT2 stabilizes Myc oncoproteins. Cell Death Differ 20(3):503\u2013514. https:\/\/doi.org\/10.1038\/cdd.2012.147","journal-title":"Cell Death Differ"},{"key":"1281_CR82","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3389\/fonc.2020.00865","volume":"10","author":"D Liu","year":"2020","unstructured":"Liu D, Song Z, Wang X, Ouyang L (2020) Ubiquitin C-terminal hydrolase L5 (UCHL5) accelerates the growth of endometrial cancer via activating the Wnt\/beta-catenin signaling pathway. Front Oncol 10:865. https:\/\/doi.org\/10.3389\/fonc.2020.00865","journal-title":"Front Oncol"},{"issue":"20","key":"1281_CR85","doi-asserted-by":"publisher","first-page":"11364","DOI":"10.1073\/pnas.96.20.11364","volume":"96","author":"KL Lorick","year":"1999","unstructured":"Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S, Weissman AM (1999) RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci USA 96(20):11364\u201311369. https:\/\/doi.org\/10.1073\/pnas.96.20.11364","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1281_CR87","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.4161\/auto.21484","volume":"8","author":"Z Luo","year":"2012","unstructured":"Luo Z, Pan Y, Jeong LS, Liu J, Jia L (2012) Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells. Autophagy 8(11):1677\u20131679. https:\/\/doi.org\/10.4161\/auto.21484","journal-title":"Autophagy"},{"issue":"1","key":"1281_CR86","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3892\/mmr.2017.6587","volume":"16","author":"G Luo","year":"2017","unstructured":"Luo G, Hu N, Xia X, Zhou J, Ye C (2017) RPN11 deubiquitinase promotes proliferation and migration of breast cancer cells. Mol Med Rep 16(1):331\u2013338. https:\/\/doi.org\/10.3892\/mmr.2017.6587","journal-title":"Mol Med Rep"},{"issue":"1","key":"1281_CR88","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41392-020-0143-9","volume":"5","author":"YS Ma","year":"2020","unstructured":"Ma YS, Wang XF, Yu F, Wu TM, Liu JB, Zhang YJ, Xia Q, Jiang ZY, Lin QL, Fu D (2020) Inhibition of USP14 and UCH37 deubiquitinating activity by b-AP15 as a potential therapy for tumors with p53 deficiency. Signal Transduct Target Ther 5(1):30. https:\/\/doi.org\/10.1038\/s41392-020-0143-9","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"1281_CR89","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ccr.2010.10.028","volume":"18","author":"E Manchado","year":"2010","unstructured":"Manchado E, Guillamot M, de Carcer G, Eguren M, Trickey M, Garcia-Higuera I, Moreno S, Yamano H, Canamero M, Malumbres M (2010) Targeting mitotic exit leads to tumor regression in vivo: modulation by Cdk1, Mastl, and the PP2A\/B55alpha, delta phosphatase. Cancer Cell 18(6):641\u2013654. https:\/\/doi.org\/10.1016\/j.ccr.2010.10.028","journal-title":"Cancer Cell"},{"issue":"21","key":"1281_CR90","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1200\/JCO.2005.05.081","volume":"23","author":"A Mani","year":"2005","unstructured":"Mani A, Gelmann EP (2005) The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol 23(21):4776\u20134789. https:\/\/doi.org\/10.1200\/JCO.2005.05.081","journal-title":"J Clin Oncol"},{"issue":"7018","key":"1281_CR91","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nature03155","volume":"432","author":"JH Mao","year":"2004","unstructured":"Mao JH, Perez-Losada J, Wu D, Delrosario R, Tsunematsu R, Nakayama KI, Brown K, Bryson S, Balmain A (2004) Fbxw7\/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 432(7018):775\u2013779. https:\/\/doi.org\/10.1038\/nature03155","journal-title":"Nature"},{"issue":"1","key":"1281_CR92","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1084\/jem.20082044","volume":"206","author":"R Massoumi","year":"2009","unstructured":"Massoumi R, Kuphal S, Hellerbrand C, Haas B, Wild P, Spruss T, Pfeifer A, Fassler R, Bosserhoff AK (2009) Down-regulation of CYLD expression by snail promotes tumor progression in malignant melanoma. J Exp Med 206(1):221\u2013232. https:\/\/doi.org\/10.1084\/jem.20082044","journal-title":"J Exp Med"},{"key":"1281_CR93","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/978-94-017-9421-3_11","volume-title":"Stress response pathways in cancer","author":"L Mata-Cantero","year":"2015","unstructured":"Mata-Cantero L, Lobato-Gil S, Aillet F, Lang V, Rodriguez MS (2015) The ubiquitin-proteasome system (UPS) as a cancer drug target: emerging mechanisms and therapeutics. In: Wondrak G (ed) Stress response pathways in cancer. Springer, Dordrecht, pp 225\u2013264. https:\/\/doi.org\/10.1007\/978-94-017-9421-3_11"},{"issue":"9","key":"1281_CR94","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s00018-014-1781-2","volume":"72","author":"JE McKeon","year":"2015","unstructured":"McKeon JE, Sha D, Li L, Chin LS (2015) Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system. Cell Mol Life Sci 72(9):1811\u20131824. https:\/\/doi.org\/10.1007\/s00018-014-1781-2","journal-title":"Cell Mol Life Sci"},{"issue":"6853","key":"1281_CR95","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/35095068","volume":"413","author":"KH Moberg","year":"2001","unstructured":"Moberg KH, Bell DW, Wahrer DC, Haber DA, Hariharan IK (2001) Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 413(6853):311\u2013316. https:\/\/doi.org\/10.1038\/35095068","journal-title":"Nature"},{"issue":"7","key":"1281_CR96","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/gtc.12250","volume":"20","author":"T Nakagawa","year":"2015","unstructured":"Nakagawa T, Nakayama K (2015) Protein monoubiquitylation: targets and diverse functions. Genes Cells 20(7):543\u2013562. https:\/\/doi.org\/10.1111\/gtc.12250","journal-title":"Genes Cells"},{"key":"1281_CR97","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1478-811X-11-52","volume":"11","author":"LK Nguyen","year":"2013","unstructured":"Nguyen LK, Kolch W, Kholodenko BN (2013) When ubiquitination meets phosphorylation: a systems biology perspective of EGFR\/MAPK signalling. Cell Commun Signal 11:52. https:\/\/doi.org\/10.1186\/1478-811X-11-52","journal-title":"Cell Commun Signal"},{"issue":"3","key":"1281_CR98","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.celrep.2017.09.072","volume":"21","author":"L Novellasdemunt","year":"2017","unstructured":"Novellasdemunt L, Foglizzo V, Cuadrado L, Antas P, Kucharska A, Encheva V, Snijders AP, Li VSW (2017) USP7 Is a tumor-specific WNT activator for APC-mutated colorectal cancer by mediating beta-catenin deubiquitination. Cell Rep 21(3):612\u2013627. https:\/\/doi.org\/10.1016\/j.celrep.2017.09.072","journal-title":"Cell Rep"},{"key":"1281_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20235997","author":"J Park","year":"2019","unstructured":"Park J, Cho J, Kim EE, Song EJ (2019) Deubiquitinating enzymes: a critical regulator of mitosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20235997","journal-title":"Int J Mol Sci"},{"issue":"17","key":"1281_CR100","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.4155\/fmc-2018-0091","volume":"10","author":"K Patel","year":"2018","unstructured":"Patel K, Ahmed ZS, Huang X, Yang Q, Ekinci E, Neslund-Dudas CM, Mitra B, Elnady FA, Ahn YH, Yang H, Liu J, Dou QP (2018) Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition. Future Med Chem 10(17):2087\u20132108. https:\/\/doi.org\/10.4155\/fmc-2018-0091","journal-title":"Future Med Chem"},{"issue":"5","key":"1281_CR101","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.molcel.2009.11.015","volume":"36","author":"A Peth","year":"2009","unstructured":"Peth A, Besche HC, Goldberg AL (2009) Ubiquitinated proteins activate the proteasome by binding to Usp14\/Ubp6, which causes 20S gate opening. Mol Cell 36(5):794\u2013804. https:\/\/doi.org\/10.1016\/j.molcel.2009.11.015","journal-title":"Mol Cell"},{"issue":"6467","key":"1281_CR102","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.aax3769","volume":"366","author":"C Pohl","year":"2019","unstructured":"Pohl C, Dikic I (2019) Cellular quality control by the ubiquitin-proteasome system and autophagy. Science 366(6467):818\u2013822. https:\/\/doi.org\/10.1126\/science.aax3769","journal-title":"Science"},{"issue":"17","key":"1281_CR103","doi-asserted-by":"publisher","first-page":"8625","DOI":"10.1158\/0008-5472.CAN-06-1374","volume":"66","author":"C Priolo","year":"2006","unstructured":"Priolo C, Tang D, Brahamandan M, Benassi B, Sicinska E, Ogino S, Farsetti A, Porrello A, Finn S, Zimmermann J, Febbo P, Loda M (2006) The isopeptidase USP2a protects human prostate cancer from apoptosis. Cancer Res 66(17):8625\u20138632. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-1374","journal-title":"Cancer Res"},{"issue":"8","key":"1281_CR104","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1182\/blood-2012-02-406074","volume":"120","author":"M Pulvino","year":"2012","unstructured":"Pulvino M, Liang Y, Oleksyn D, DeRan M, Van Pelt E, Shapiro J, Sanz I, Chen L, Zhao J (2012) Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A. Blood 120(8):1668\u20131677. https:\/\/doi.org\/10.1182\/blood-2012-02-406074","journal-title":"Blood"},{"issue":"6978","key":"1281_CR105","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nature02313","volume":"428","author":"H Rajagopalan","year":"2004","unstructured":"Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B, Lengauer C (2004) Inactivation of hCDC4 can cause chromosomal instability. Nature 428(6978):77\u201381. https:\/\/doi.org\/10.1038\/nature02313","journal-title":"Nature"},{"issue":"10","key":"1281_CR106","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1128\/MCB.25.10.3886-3895.2005","volume":"25","author":"W Reiley","year":"2005","unstructured":"Reiley W, Zhang M, Wu X, Granger E, Sun SC (2005) Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation. Mol Cell Biol 25(10):3886\u20133895. https:\/\/doi.org\/10.1128\/MCB.25.10.3886-3895.2005","journal-title":"Mol Cell Biol"},{"issue":"7035","key":"1281_CR107","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature03319","volume":"434","author":"T Reya","year":"2005","unstructured":"Reya T, Clevers H (2005) Wnt signalling in stem cells and cancer. Nature 434(7035):843\u2013850. https:\/\/doi.org\/10.1038\/nature03319","journal-title":"Nature"},{"key":"1281_CR108","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1146\/annurev.biochem.78.082307.091526","volume":"78","author":"FE Reyes-Turcu","year":"2009","unstructured":"Reyes-Turcu FE, Ventii KH, Wilkinson KD (2009) Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem 78:363\u2013397. https:\/\/doi.org\/10.1146\/annurev.biochem.78.082307.091526","journal-title":"Annu Rev Biochem"},{"issue":"12","key":"1281_CR109","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1002\/stem.753","volume":"29","author":"A Sato","year":"2011","unstructured":"Sato A, Sunayama J, Matsuda K, Seino S, Suzuki K, Watanabe E, Tachibana K, Tomiyama A, Kayama T, Kitanaka C (2011) MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis. Stem Cells 29(12):1942\u20131951. https:\/\/doi.org\/10.1002\/stem.753","journal-title":"Stem Cells"},{"issue":"6509","key":"1281_CR110","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/373081a0","volume":"373","author":"M Scheffner","year":"1995","unstructured":"Scheffner M, Nuber U, Huibregtse JM (1995) Protein ubiquitination involving an E1\u2013E2-E3 enzyme ubiquitin thioester cascade. Nature 373(6509):81\u201383. https:\/\/doi.org\/10.1038\/373081a0","journal-title":"Nature"},{"key":"1281_CR111","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.drup.2015.06.001","volume":"21\u201322","author":"K Selvaraju","year":"2015","unstructured":"Selvaraju K, Mazurkiewicz M, Wang X, Gullbo J, Linder S, D\u2019Arcy P (2015) Inhibition of proteasome deubiquitinase activity: a strategy to overcome resistance to conventional proteasome inhibitors? Drug Resist Updates 21\u201322:20\u201329. https:\/\/doi.org\/10.1016\/j.drup.2015.06.001","journal-title":"Drug Resist Updates"},{"issue":"2","key":"1281_CR112","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrc.2017.105","volume":"18","author":"D Senft","year":"2018","unstructured":"Senft D, Qi J, Ronai ZA (2018) Ubiquitin ligases in oncogenic transformation and cancer therapy. Nat Rev Cancer 18(2):69\u201388. https:\/\/doi.org\/10.1038\/nrc.2017.105","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1281_CR115","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bbrc.2007.08.185","volume":"363","author":"N Shabek","year":"2007","unstructured":"Shabek N, Iwai K, Ciechanover A (2007) Ubiquitin is degraded by the ubiquitin system as a monomer and as part of its conjugated target. Biochem Biophys Res Commun 363(2):425\u2013431. https:\/\/doi.org\/10.1016\/j.bbrc.2007.08.185","journal-title":"Biochem Biophys Res Commun"},{"issue":"29","key":"1281_CR114","doi-asserted-by":"publisher","first-page":"11907","DOI":"10.1073\/pnas.0905746106","volume":"106","author":"N Shabek","year":"2009","unstructured":"Shabek N, Herman-Bachinsky Y, Ciechanover A (2009) Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation. Proc Natl Acad Sci USA 106(29):11907\u201311912. https:\/\/doi.org\/10.1073\/pnas.0905746106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1281_CR113","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molcel.2012.07.011","volume":"48","author":"N Shabek","year":"2012","unstructured":"Shabek N, Herman-Bachinsky Y, Buchsbaum S, Lewinson O, Haj-Yahya M, Hejjaoui M, Lashuel HA, Sommer T, Brik A, Ciechanover A (2012) The size of the proteasomal substrate determines whether its degradation will be mediated by mono- or polyubiquitylation. Mol Cell 48(1):87\u201397. https:\/\/doi.org\/10.1016\/j.molcel.2012.07.011","journal-title":"Mol Cell"},{"issue":"3","key":"1281_CR116","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.molcel.2009.10.018","volume":"36","author":"J Shan","year":"2009","unstructured":"Shan J, Zhao W, Gu W (2009) Suppression of cancer cell growth by promoting cyclin D1 degradation. Mol Cell 36(3):469\u2013476. https:\/\/doi.org\/10.1016\/j.molcel.2009.10.018","journal-title":"Mol Cell"},{"issue":"17","key":"1281_CR117","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1158\/1078-0432.CCR-07-5136","volume":"14","author":"S Shangary","year":"2008","unstructured":"Shangary S, Wang S (2008) Targeting the MDM2-p53 interaction for cancer therapy. Clin Cancer Res 14(17):5318\u20135324. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-5136","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1281_CR118","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1096\/fj.201601240R","volume":"31","author":"W Sheng","year":"2017","unstructured":"Sheng W, Dong M, Chen C, Wang Z, Li Y, Wang K, Li Y, Zhou J (2017) Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer. FASEB J 31(6):2429\u20132438. https:\/\/doi.org\/10.1096\/fj.201601240R","journal-title":"FASEB J"},{"issue":"7214","key":"1281_CR119","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nature07290","volume":"455","author":"MS Song","year":"2008","unstructured":"Song MS, Salmena L, Carracedo A, Egia A, Lo-Coco F, Teruya-Feldstein J, Pandolfi PP (2008) The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455(7214):813\u2013817. https:\/\/doi.org\/10.1038\/nature07290","journal-title":"Nature"},{"issue":"40","key":"1281_CR120","doi-asserted-by":"publisher","first-page":"5631","DOI":"10.1038\/onc.2017.172","volume":"36","author":"Y Song","year":"2017","unstructured":"Song Y, Li S, Ray A, Das DS, Qi J, Samur MK, Tai YT, Munshi N, Carrasco RD, Chauhan D, Anderson KC (2017) Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Oncogene 36(40):5631\u20135638. https:\/\/doi.org\/10.1038\/onc.2017.172","journal-title":"Oncogene"},{"issue":"7239","key":"1281_CR121","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nature07884","volume":"458","author":"TA Soucy","year":"2009","unstructured":"Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, Adhikari S, Brownell JE, Burke KE, Cardin DP, Critchley S, Cullis CA, Doucette A, Garnsey JJ, Gaulin JL, Gershman RE, Lublinsky AR, McDonald A, Mizutani H, Narayanan U, Olhava EJ, Peluso S, Rezaei M, Sintchak MD, Talreja T, Thomas MP, Traore T, Vyskocil S, Weatherhead GS, Yu J, Zhang J, Dick LR, Claiborne CF, Rolfe M, Bolen JB, Langston SP (2009) An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458(7239):732\u2013736. https:\/\/doi.org\/10.1038\/nature07884","journal-title":"Nature"},{"issue":"4","key":"1281_CR122","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/sj.emboj.7601567","volume":"26","author":"LF Stevenson","year":"2007","unstructured":"Stevenson LF, Sparks A, Allende-Vega N, Xirodimas DP, Lane DP, Saville MK (2007) The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2. EMBO J 26(4):976\u2013986. https:\/\/doi.org\/10.1038\/sj.emboj.7601567","journal-title":"EMBO J"},{"issue":"2","key":"1281_CR123","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1411321","volume":"372","author":"AK Stewart","year":"2015","unstructured":"Stewart AK, Rajkumar SV, Dimopoulos MA, Masszi T, Spicka I, Oriol A, Hajek R, Rosinol L, Siegel DS, Mihaylov GG, Goranova-Marinova V, Rajnics P, Suvorov A, Niesvizky R, Jakubowiak AJ, San-Miguel JF, Ludwig H, Wang M, Maisnar V, Minarik J, Bensinger WI, Mateos MV, Ben-Yehuda D, Kukreti V, Zojwalla N, Tonda ME, Yang X, Xing B, Moreau P, Palumbo A, Investigators A (2015) Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma. N Engl J Med 372(2):142\u2013152. https:\/\/doi.org\/10.1056\/NEJMoa1411321","journal-title":"N Engl J Med"},{"issue":"6853","key":"1281_CR124","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/35095076","volume":"413","author":"H Strohmaier","year":"2001","unstructured":"Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI (2001) Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413(6853):316\u2013322. https:\/\/doi.org\/10.1038\/35095076","journal-title":"Nature"},{"issue":"2","key":"1281_CR125","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1349-7006.1998.tb00552.x","volume":"89","author":"A Suzuki","year":"1998","unstructured":"Suzuki A, Toi M, Yamamoto Y, Saji S, Muta M, Tominaga T (1998) Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma. Jpn J Cancer Res 89(2):221\u2013227. https:\/\/doi.org\/10.1111\/j.1349-7006.1998.tb00552.x","journal-title":"Jpn J Cancer Res"},{"issue":"18","key":"1281_CR126","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1182\/blood-2009-11-254862","volume":"115","author":"RT Swords","year":"2010","unstructured":"Swords RT, Kelly KR, Smith PG, Garnsey JJ, Mahalingam D, Medina E, Oberheu K, Padmanabhan S, O\u2019Dwyer M, Nawrocki ST, Giles FJ, Carew JS (2010) Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia. Blood 115(18):3796\u20133800. https:\/\/doi.org\/10.1182\/blood-2009-11-254862","journal-title":"Blood"},{"issue":"5","key":"1281_CR127","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.molcel.2010.01.035","volume":"37","author":"DV Tauriello","year":"2010","unstructured":"Tauriello DV, Haegebarth A, Kuper I, Edelmann MJ, Henraat M, Canninga-van Dijk MR, Kessler BM, Clevers H, Maurice MM (2010) Loss of the tumor suppressor CYLD enhances Wnt\/beta-catenin signaling through K63-linked ubiquitination of Dvl. Mol Cell 37(5):607\u2013619. https:\/\/doi.org\/10.1016\/j.molcel.2010.01.035","journal-title":"Mol Cell"},{"issue":"1","key":"1281_CR128","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/jmcb\/mjw049","volume":"9","author":"O Tavana","year":"2017","unstructured":"Tavana O, Gu W (2017) Modulation of the p53\/MDM2 interplay by HAUSP inhibitors. J Mol Cell Biol 9(1):45\u201352. https:\/\/doi.org\/10.1093\/jmcb\/mjw049","journal-title":"J Mol Cell Biol"},{"issue":"2","key":"1281_CR129","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.immuni.2010.07.017","volume":"33","author":"RM Tavares","year":"2010","unstructured":"Tavares RM, Turer EE, Liu CL, Advincula R, Scapini P, Rhee L, Barrera J, Lowell CA, Utz PJ, Malynn BA, Ma A (2010) The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity 33(2):181\u2013191. https:\/\/doi.org\/10.1016\/j.immuni.2010.07.017","journal-title":"Immunity"},{"issue":"5659","key":"1281_CR130","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1126\/science.1092472","volume":"303","author":"LT Vassilev","year":"2004","unstructured":"Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303(5659):844\u2013848. https:\/\/doi.org\/10.1126\/science.1092472","journal-title":"Science"},{"issue":"5593","key":"1281_CR131","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1126\/science.1075898","volume":"298","author":"R Verma","year":"2002","unstructured":"Verma R, Aravind L, Oania R, McDonald WH, Yates JR 3rd, Koonin EV, Deshaies RJ (2002) Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 298(5593):611\u2013615. https:\/\/doi.org\/10.1126\/science.1075898","journal-title":"Science"},{"key":"1281_CR132","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1146\/annurev.biochem.68.1.1015","volume":"68","author":"D Voges","year":"1999","unstructured":"Voges D, Zwickl P, Baumeister W (1999) The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 68:1015\u20131068. https:\/\/doi.org\/10.1146\/annurev.biochem.68.1.1015","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"1281_CR133","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1158\/2159-8290.CD-16-0647","volume":"7","author":"L Wan","year":"2017","unstructured":"Wan L, Chen M, Cao J, Dai X, Yin Q, Zhang J, Song SJ, Lu Y, Liu J, Inuzuka H, Katon JM, Berry K, Fung J, Ng C, Liu P, Song MS, Xue L, Bronson RT, Kirschner MW, Cui R, Pandolfi PP, Wei W (2017) The APC\/C E3 ligase complex activator FZR1 restricts BRAF oncogenic function. Cancer Discov 7(4):424\u2013441. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0647","journal-title":"Cancer Discov"},{"issue":"18","key":"1281_CR136","doi-asserted-by":"publisher","first-page":"7953","DOI":"10.1128\/MCB.25.18.7953-7965.2005","volume":"25","author":"L Wang","year":"2005","unstructured":"Wang L, Baiocchi RA, Pal S, Mosialos G, Caligiuri M, Sif S (2005) The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene. Mol Cell Biol 25(18):7953\u20137965. https:\/\/doi.org\/10.1128\/MCB.25.18.7953-7965.2005","journal-title":"Mol Cell Biol"},{"issue":"1","key":"1281_CR140","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cell.2006.11.039","volume":"128","author":"X Wang","year":"2007","unstructured":"Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, Gao Z, Wang J, Erdjument-Bromage H, Tempst P, Cordon-Cardo C, Pandolfi PP, Jiang X (2007) NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128(1):129\u2013139. https:\/\/doi.org\/10.1016\/j.cell.2006.11.039","journal-title":"Cell"},{"issue":"2","key":"1281_CR139","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1042\/BJ20080674","volume":"414","author":"X Wang","year":"2008","unstructured":"Wang X, Shi Y, Wang J, Huang G, Jiang X (2008) Crucial role of the C-terminus of PTEN in antagonizing NEDD4-1-mediated PTEN ubiquitination and degradation. Biochem J 414(2):221\u2013229. https:\/\/doi.org\/10.1042\/BJ20080674","journal-title":"Biochem J"},{"issue":"18","key":"1281_CR141","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.2174\/1381612811319180005","volume":"19","author":"Z Wang","year":"2013","unstructured":"Wang Z, Wan L, Zhong J, Inuzuka H, Liu P, Sarkar FH, Wei W (2013) Cdc20: a potential novel therapeutic target for cancer treatment. Curr Pharm Des 19(18):3210\u20133214. https:\/\/doi.org\/10.2174\/1381612811319180005","journal-title":"Curr Pharm Des"},{"issue":"7","key":"1281_CR135","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/carcin\/bgu015","volume":"35","author":"CL Wang","year":"2014","unstructured":"Wang CL, Wang JY, Liu ZY, Ma XM, Wang XW, Jin H, Zhang XP, Fu D, Hou LJ, Lu YC (2014a) Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma. Carcinogenesis 35(7):1500\u20131509. https:\/\/doi.org\/10.1093\/carcin\/bgu015","journal-title":"Carcinogenesis"},{"issue":"11","key":"1281_CR137","doi-asserted-by":"publisher","first-page":"11427","DOI":"10.1007\/s13277-014-2446-3","volume":"35","author":"L Wang","year":"2014","unstructured":"Wang L, Chen YJ, Xu K, Wang YY, Shen XZ, Tu RQ (2014b) High expression of UCH37 is significantly associated with poor prognosis in human epithelial ovarian cancer. Tumour Biol 35(11):11427\u201311433. https:\/\/doi.org\/10.1007\/s13277-014-2446-3","journal-title":"Tumour Biol"},{"key":"1281_CR134","doi-asserted-by":"publisher","first-page":"8704","DOI":"10.1038\/ncomms9704","volume":"6","author":"B Wang","year":"2015","unstructured":"Wang B, Ma A, Zhang L, Jin WL, Qian Y, Xu G, Qiu B, Yang Z, Liu Y, Xia Q, Liu Y (2015) POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation. Nat Commun 6:8704. https:\/\/doi.org\/10.1038\/ncomms9704","journal-title":"Nat Commun"},{"issue":"6","key":"1281_CR138","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1172\/JCI85747","volume":"126","author":"Q Wang","year":"2016","unstructured":"Wang Q, Ma S, Song N, Li X, Liu L, Yang S, Ding X, Shan L, Zhou X, Su D, Wang Y, Zhang Q, Liu X, Yu N, Zhang K, Shang Y, Yao Z, Shi L (2016) Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis. J Clin Invest 126(6):2205\u20132220. https:\/\/doi.org\/10.1172\/JCI85747","journal-title":"J Clin Invest"},{"issue":"7349","key":"1281_CR142","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature09966","volume":"474","author":"DM Wenzel","year":"2011","unstructured":"Wenzel DM, Lissounov A, Brzovic PS, Klevit RE (2011) UBCH7 reactivity profile reveals parkin and HHARI to be RING\/HECT hybrids. Nature 474(7349):105\u2013108. https:\/\/doi.org\/10.1038\/nature09966","journal-title":"Nature"},{"issue":"54","key":"1281_CR143","doi-asserted-by":"publisher","first-page":"8080","DOI":"10.1038\/sj.onc.1208944","volume":"24","author":"SJ Wicks","year":"2005","unstructured":"Wicks SJ, Haros K, Maillard M, Song L, Cohen RE, Dijke PT, Chantry A (2005) The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling. Oncogene 24(54):8080\u20138084. https:\/\/doi.org\/10.1038\/sj.onc.1208944","journal-title":"Oncogene"},{"issue":"6","key":"1281_CR144","doi-asserted-by":"publisher","first-page":"10749","DOI":"10.3390\/ijms140610749","volume":"14","author":"N Wu","year":"2013","unstructured":"Wu N, Liu C, Bai C, Han YP, Cho WC, Li Q (2013) Over-expression of deubiquitinating enzyme USP14 in lung adenocarcinoma promotes proliferation through the accumulation of beta-catenin. Int J Mol Sci 14(6):10749\u201310760. https:\/\/doi.org\/10.3390\/ijms140610749","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1281_CR145","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13046-019-1227-7","volume":"38","author":"X Xia","year":"2019","unstructured":"Xia X, Huang C, Liao Y, Liu Y, He J, Guo Z, Jiang L, Wang X, Liu J, Huang H (2019) Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide. J Exp Clin Cancer Res 38(1):220. https:\/\/doi.org\/10.1186\/s13046-019-1227-7","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"1281_CR146","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/onc.2013.557","volume":"34","author":"C Xu","year":"2015","unstructured":"Xu C, Fan CD, Wang X (2015) Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase. Oncogene 34(3):281\u2013289. https:\/\/doi.org\/10.1038\/onc.2013.557","journal-title":"Oncogene"},{"issue":"1","key":"1281_CR147","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cell.2009.01.041","volume":"137","author":"P Xu","year":"2009","unstructured":"Xu P, Duong DM, Seyfried NT, Cheng D, Xie Y, Robert J, Rush J, Hochstrasser M, Finley D, Peng J (2009) Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 137(1):133\u2013145. https:\/\/doi.org\/10.1016\/j.cell.2009.01.041","journal-title":"Cell"},{"issue":"4","key":"1281_CR148","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/0008-5472.CAN-17-2143","volume":"78","author":"C Yang","year":"2018","unstructured":"Yang C, Zang W, Tang Z, Ji Y, Xu R, Yang Y, Luo A, Hu B, Zhang Z, Liu Z, Zheng X (2018) A20\/TNFAIP3 regulates the DNA damage response and mediates tumor cell resistance to DNA-damaging therapy. Cancer Res 78(4):1069\u20131082. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2143","journal-title":"Cancer Res"},{"issue":"8","key":"1281_CR149","doi-asserted-by":"publisher","first-page":"6310","DOI":"10.18632\/oncotarget.3355","volume":"6","author":"H Yang","year":"2015","unstructured":"Yang H, Lu X, Liu Z, Chen L, Xu Y, Wang Y, Wei G, Chen Y (2015) FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells. Oncotarget 6(8):6310\u20136325. https:\/\/doi.org\/10.18632\/oncotarget.3355","journal-title":"Oncotarget"},{"key":"1281_CR150","doi-asserted-by":"publisher","first-page":"e1059","DOI":"10.1038\/cddis.2014.21","volume":"5","author":"WT Yao","year":"2014","unstructured":"Yao WT, Wu JF, Yu GY, Wang R, Wang K, Li LH, Chen P, Jiang YN, Cheng H, Lee HW, Yu J, Qi H, Yu XJ, Wang P, Chu YW, Yang M, Hua ZC, Ying HQ, Hoffman RM, Jeong LS, Jia LJ (2014) Suppression of tumor angiogenesis by targeting the protein neddylation pathway. Cell Death Dis 5:e1059. https:\/\/doi.org\/10.1038\/cddis.2014.21","journal-title":"Cell Death Dis"},{"key":"1281_CR151","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3389\/fphar.2018.01080","volume":"9","author":"T Yuan","year":"2018","unstructured":"Yuan T, Yan F, Ying M, Cao J, He Q, Zhu H, Yang B (2018) Inhibition of ubiquitin-specific proteases as a novel anticancer therapeutic strategy. Front Pharmacol 9:1080. https:\/\/doi.org\/10.3389\/fphar.2018.01080","journal-title":"Front Pharmacol"},{"issue":"3","key":"1281_CR152","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.celrep.2014.03.045","volume":"7","author":"T Zeng","year":"2014","unstructured":"Zeng T, Wang Q, Fu J, Lin Q, Bi J, Ding W, Qiao Y, Zhang S, Zhao W, Lin H, Wang M, Lu B, Deng X, Zhou D, Yin Z, Wang HR (2014) Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis. Cell Rep 7(3):871\u2013882. https:\/\/doi.org\/10.1016\/j.celrep.2014.03.045","journal-title":"Cell Rep"},{"issue":"2","key":"1281_CR153","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bbcan.2014.02.001","volume":"1845","author":"J Zhang","year":"2014","unstructured":"Zhang J, Wan L, Dai X, Sun Y, Wei W (2014) Functional characterization of anaphase promoting complex\/cyclosome (APC\/C) E3 ubiquitin ligases in tumorigenesis. Biochim Biophys Acta 1845(2):277\u2013293. https:\/\/doi.org\/10.1016\/j.bbcan.2014.02.001","journal-title":"Biochim Biophys Acta"},{"key":"1281_CR154","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040902","author":"X Zhang","year":"2020","unstructured":"Zhang X, Linder S, Bazzaro M (2020) Drug development targeting the ubiquitin-proteasome system (UPS) for the treatment of human cancers. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12040902","journal-title":"Cancers (Basel)"},{"issue":"30","key":"1281_CR155","doi-asserted-by":"publisher","first-page":"48725","DOI":"10.18632\/oncotarget.10706","volume":"8","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Zhang Y, Sui Z, Zhang Y, Liu M, Tang H (2017) USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells. Oncotarget 8(30):48725\u201348736. https:\/\/doi.org\/10.18632\/oncotarget.10706","journal-title":"Oncotarget"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-020-01281-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-020-01281-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-020-01281-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:02:39Z","timestamp":1744167759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-020-01281-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":155,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1281"],"URL":"https:\/\/doi.org\/10.1007\/s12272-020-01281-8","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"27 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declares that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}